Cell + Gene: Unfiltered

Michael Adeniya
  • 0.0 (0)
  • Life Sciences
  • Updated Bimonthly

A podcast for the cell and gene therapy community. Advanced therapies are revolutionizing the way disease is treated, but existing therapies have their limits. Anthony Davies and Michael Adeniya expose the truth through candid conversations with the greatest minds in cell and gene therapy.

Episodes

  1. 08/27/2023

    Ep1: what gives investors the ‘ick’?

    Jason Mellad, CEO at Start Codon and Mark Bonyhadi at Qiming Ventures kick off the podcast in episode one of Cell and Gene: Unfiltered.   We talk about what gives them ‘the ick’ and some of the most common cardinal mistakes made during investor pitches.   Our guests show no signs of dancing around the issues and discussing what makes investors perk up and pay attention. Does novelty immediately make a product investment worthy? The answer is a firm ‘no’ from Jason…   We also reflect on the collapse of SVB, the European rescue by HSBC, and the potential impact for the CGT field.   Don’t miss Mark and Anthony’s Christmas wish list of tech too! Tune in for no-nonsense, actionable, specific advice and insights from two uniquely experienced execs. Send us your feedback at info@cgtunfiltered.com

    Ep1: what gives investors the ‘ick’?
  • 1 Episode

About

A podcast for the cell and gene therapy community. Advanced therapies are revolutionizing the way disease is treated, but existing therapies have their limits. Anthony Davies and Michael Adeniya expose the truth through candid conversations with the greatest minds in cell and gene therapy.

Information